Clinical Interventions to Mitigate Neurodevelopmental Risk
Sponsor: Columbia University
Terminated
The COVID-19 pandemic lead to halted protocols containing human subjects and in person interactions
Other terminated trials from Columbia University
Other Child Development trials with similar outcome
This NA trial investigates Child Development and Diabetes Mellitus, Gestational and is currently terminated or withdrawn. Columbia University leads this study, which shows 5 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Nov 2022 — Jul 2024 [monthly]
Terminated NA
Status: Not Yet Recruiting → Terminated
-
Jan 2021 — Nov 2022 [monthly]
Not Yet Recruiting NA
-
Feb 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
First recorded
Jan 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Columbia University
- New York State Psychiatric Institute
For direct contact, visit the study record on ClinicalTrials.gov .